Molecular biology and pathogenesis of Crimean-Congo hemorrhagic fever virus

Future Virology

Volumn 5, Issue 4, 2010, Pages 469-479

  Kraus, Annette A ^a,b   Mirazimi, Ali ^a,b  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Bunyaviridae family; Crimean Congo hemorrhagic fever virus; hemorrhagic fever; reverse genetics; viral life cycle; virus genome structure; virus host cell interactions

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; NEOPTERIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS GLYCOPROTEIN; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLEEDING; BUNYAVIRUS; CRIMEAN CONGO HEMORRHAGIC FEVER; DEATH; DISEASE CARRIER; DISSEMINATED INTRAVASCULAR CLOTTING; FEVER; GENETIC ORGANIZATION; GEOGRAPHIC DISTRIBUTION; HEAT EXHAUSTION; HUMAN; LIFE CYCLE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS GENE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

BUNYAVIRIDAE; CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS;

EID: 77954933074     PISSN: 17460794     EISSN: None     Source Type: Journal    
DOI: 10.2217/fvl.10.23     Document Type: Review

References (111)

1. Ergonul O: Crimean-Congo haemorrhagic fever. Lancet Infect. Dis. 6(4), 203-214 (2006).
2. Simpson DI, Knight EM, Courtois G, Williams MC, Weinbren MP, Kibukamusoke JW: Congo virus: a hitherto undescribed virus occurring in Africa. I. Human isolations - clinical notes. East Afr. Med. J. 44(2), 86-92 (1967).
3. Begum F, Wisseman CL Jr, Casals J: Tick-borne viruses of west Pakistan. II. Hazara virus, a new agent isolated from Ixodes redikorzevi ticks from the Kaghan Valley W Pakistan. Am. J. Epidemiol. 92(3), 192-194 (1970).
4. Casals J: Antigenic similarity between the virus causing Crimean hemorrhagic fever and Congo virus. Proc. Soc. Exp. Biol. Med. 131(1), 233-236 (1969).
5. Casals J, Henderson BE, Hoogstraal H, Johnson KM, Shelokov A: A review of Soviet viral hemorrhagic fevers. J. Infect. Dis. 122(5), 437-453 (1969).
6. Nichol S: Bunyaviruses. In: Fields Virology. Knipe D, Howley P (Eds). Lippincott Williams and Wilkins, PA, USA 1603-1633 (2001).
7. Burt FJ, Spencer DC, Leman PA, Patterson B, Swanepoel R: Investigation of tick-borne viruses as pathogens of humans in South Africa and evidence of Dugbe virus infection in a patient with prolonged thrombocytopenia. Epidemiol. Infect. 116(3), 353-361 (1996).
8. Hoogstraal H: The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J. Med. Entomol. 15(4), 307-417 (1979).
9. Watts DM et al.: Crimean Congo Hemorrahgic Fever, in the Arboviruses: Epidemiology and Ecology (Vol. II). Monath TP (Ed.). CRC Press, Boca Raton, FL, USA, 177-222 (1988).
10. Dunster L, Dunster M, Ofula V et al.: First documentation of human Crimean- Congo hemorrhagic fever, Kenya. Emerg. Infect. Dis. 8(9), 1005-1006 (2002).
11. Drosten C, Minnak D, Emmerich P, Schmitz H, Reinicke T: Crimean-Congo hemorrhagic fever in Kosovo. J. Clin. Microbiol. 40(3), 1122-1123 (2002).
12. Nabeth P, Thior M, Faye O, Simon F: Human Crimean-Congo hemorrhagic fever, Senegal. Emerg. Infect. Dis. 10(10), 1881-1882 (2004).
13. Nabeth P, Cheikh DO, Lo B et al.: Crimean-Congo hemorrhagic fever, Mauritania. Emerg. Infect. Dis. 10(12), 2143-2149 (2004).
14. el-Azazy OM, Scrimgeour EM: Crimean- Congo haemorrhagic fever virus infection in the western province of Saudi Arabia. Trans. R Soc. Trop. Med. Hyg. 91(3), 275-278 (1997).
15. Williams RJ, Al-Busaidy S, Mehta FR et al.: Crimean-Congo haemorrhagic fever: a seroepidemiological and tick survey in the Sultanate of Oman. Trop. Med. Int. Health 5(2), 99-106 (2000).
16. Burney MI, Ghafoor A, Saleen M, Webb PA, Casals J: Nosocomial outbreak of viral hemorrhagic fever caused by Crimean hemorrhagic fever-Congo virus in Pakistan, January 1976. Am. J. Trop. Med. Hyg. 29(5), 941-947 (1980).
17. Papa A, Bino S, Llagami A et al.: Crimean- Congo hemorrhagic fever in Albania, 2001. Eur. J. Clin. Microbiol. Infect. Dis. 21(8), 603-606 (2002).
18. Papa A, Bino S, Llagami A et al.: Crimean-Congo hemorrhagic fever in Bulgaria. Emerg. Infect. Dis. 10(8), 1465-1467 (2004).
19. Sheikh AS, Sheikh AA, Sheikh NS et al.: Bi-annual surge of Crimean-Congo haemorrhagic fever (CCHF): a five-year experience. Int. J. Infect. Dis. 9(1), 37-42 (2005).
20. Papa A, Ma B, Kouidou S, Tang Q, Hang C, Antoniadis A: Genetic characterization of the M RNA segment of Crimean Congo hemorrhagic fever virus strains, China. Emerg. Infect. Dis. 8(1), 50-53 (2002).
21. Sheikh AS, Sheikh AA, Sheikh NS et al.: A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part IV. Preventive and prophylactic measures. S. Afr. Med. J. 68(10), 729-732 (1985).
22. van Eeden PJ, van Eeden SF, Joubert JR, King JB, van de Wal BW, Michell WL: A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part II. Management of patients. S. Afr. Med. J. 68(10), 718-721 (1985).
23. Swanepoel R, Shepherd AJ, Leman PA, Shepherd SP et al.: Investigations following initial recognition of Crimean-Congo haemorrhagic fever in South Africa and the diagnosis of 2 further cases. S. Afr. Med. J. 68(9), 638-641 (1985).
24. Chinikar S, Persson SM, Johansson M et al.: Genetic analysis of Crimean-Congo hemorrhagic fever virus in Iran. J. Med. Virol. 73(3), 404-411 (2004).
25. Weber F, Mirazimi A: Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis. Cytokine Growth Factor Rev. 19(5-6), 395-404 (2008).
26. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S: The clinical pathology of Crimean-Congo hemorrhagic fever. Rev. Infect. Dis. 11(Suppl. 4), S794-S800 (1989).
27. Schwarz TF, Nsanze H, Ameen AM: Clinical features of Crimean-Congo haemorrhagic fever in the United Arab Emirates. Infection 25(6), 364-367 (1997).
28. Baskerville A, Satti A, Murphy FA, Simpson DI: Congo-Crimean haemorrhagic fever in Dubai: histopathological studies. J. Clin. Pathol. 34(8), 871-874 (1981).
29. Baskerville A, Satti A, Murphy FA, Simpson DI: Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg. Infect. Dis. 13(7), 1097-1100 (2007).
30. Duh D, Saksida A, Petrovec M et al.: Viral load as predictor of Crimean-Congo hemorrhagic fever outcome. Emerg. Infect. Dis. 13(11), 1769-1772 (2007).
31. Shepherd AJ, Swanepoel R, Leman PA: Antibody response in Crimean-Congo hemorrhagic fever. Rev. Infect. Dis. 11(Suppl. 4), S801-S806 (1989).
32. Garcia S, Chinikar S, Coudrier D et al.: Evaluation of a Crimean-Congo hemorrhagic fever virus recombinant antigen expressed by Semliki Forest suicide virus for IgM and IgG antibody detection in human and animal sera collected in Iran. J. Clin. Virol. 35(2), 154-159 (2006).
33. Saijo M, Tang Q, Shimayi B et al.: Antigen-capture enzyme-linked immunosorbent assay for the diagnosis of Crimean-Congo hemorrhagic fever using a novel monoclonal antibody. J. Med. Virol. 77(1), 83-88 (2005).
34. Burt FJ, Leman PA, Smith JF, Swanepoel R: The use of a reverse transcription-polymerase chain reaction for the detection of viral nucleic acid in the diagnosis of Crimean- Congo haemorrhagic fever. J. Virol. Methods 70(2), 129-137 (1998).
35. Drosten C, Kummerer BM, Schmitz H, Gunther S: Molecular diagnostics of viral hemorrhagic fevers. Antiviral Res. 57(1-2), 61-87 (2003).
36. Elaldi N, Bodur H, Ascioglu S et al.: Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. J. Infect. 58(3), 238-244 (2009).
37. Tignor GH, Hanham CA: Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection. Antiviral Res. 22(4), 309-325 (1993).
38. Watts DM, Ussery MA, Nash D, Peters CJ: Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin. Am. J. Trop. Med. Hyg. 41(5), 581-585 (1989).
39. Deyde VM, Khristova ML, Rollin PE, Ksiazek TG, Nichol ST: Crimean-Congo hemorrhagic fever virus genomics and global diversity. J. Virol. 80(17), 8834-8842 (2006).
40. Schnittler HJ, Feldmann H: Viral hemorrhagic fever - a vascular disease? Thromb. Haemost. 89(6), 967-972 (2003).
41. Connolly-Andersen AM, Magnusson KE, Mirazimi A: Basolateral entry and release of Crimean-Congo hemorrhagic fever virus in polarized MDCK-1 cells. J. Virol. 81(5), 2158-2164 (2007).
42. Chen HC, Hofman FM, Kung JT, Lin YD, Wu-Hsieh BA: Both virus and tumor necrosis factor-a are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J. Virol. 81(11), 5518-5526 (2007).
43. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B: Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-a in patients with Crimean-Congo hemorrhagic fever. J. Infect. Dis. 193(7), 941-944 (2006).
44. Papa A, Bino S, Velo E, Harxhi A, Kota M, Antoniadis A: Cytokine levels in Crimean-Congo hemorrhagic fever. J. Clin. Virol. 36(4), 272-276 (2006).
45. Baize S, Leroy EM, Georges AJ et al.: Inflammatory responses in Ebola virus- infected patients. Clin. Exp. Immunol. 128(1), 163-168 (2002).
46. Chan CP, Choi JW, Cao KY et al.: Detection of serum neopterin for early assessment of Dengue virus infection. J. Infect. 53(3), 152-158 (2006).
47. Wirleitner B, Reider D, Ebner S et al.: Monocyte-derived dendritic cells release neopterin. J. Leukoc. Biol. 72(6), 1148-1153 (2002).
48. Onguru P, Akgul EO, Akinci E et al.: High serum levels of neopterin in patients with Crimean-Congo hemorrhagic fever and its relation with mortality. J. Infect. 56(5), 366-370 (2008).
49. Whitehouse CA: Crimean-Congo hemorrhagic fever. Antiviral Res. 64(3), 145-160 (2004).
50. Elliott RM, Schmaljohn CS, Collett MS: Bunyaviridae genome structure and gene expression. Curr. Top. Microbiol. Immunol. 169, 91-141 (1991).
51. Flick R, Elgh F, Pettersson RF: Mutational analysis of the Uukuniemi virus (Bunyaviridae family) promoter reveals two elements of functional importance. J. Virol. 76(21), 10849-10860 (2002).
52. Blakqori G, Delhaye S, Habjan M et al.: La Crosse bunyavirus nonstructural protein NS serves to suppress the type I interferon system of mammalian hosts. J. Virol. 81(10), 4991-4999 (2007).
53. Le May N, Dubaele S, Proietti De Santis L, Billecocq A, Bouloy M, Egly JM: TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 116(4), 541-550 (2004).
54. Kormelink R, Kitajima EW, De Haan P, Zuidema D, Peters D, Goldbach R: The nonstructural protein (NS ) encoded by the ambisense S RNA segment of tomato spotted wilt virus is associated with fibrous structures in infected plant cells. Virology 181(2), 459-468 (1991).
55. Fuller F, Bhown AS, Bishop DH: Bunyavirus nucleoprotein, N, and a non-structural protein, NS , are coded by overlapping reading frames in theS RNA.J. Gen. Virol. 64(Pt 8), 1705-1714 (1983).
56. Jaaskelainen KM, Kaukinen P, Minskaya ES et al.: Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-p promoter. J. Med. Virol. 79(10), 1527-1536 (2007).
57. Bergeron E, Vincent MJ, Nichol ST: Crimean-Congo hemorrhagic fever virus glycoprotein processing by the endoprotease SKI-1/S1P is critical for virus infectivity. J. Virol. 81(23), 13271-13276 (2007).
58. Fontana J, Lopez-Montero N, Elliott RM, Fernandez JJ, Risco C: The unique architecture of Bunyamwera virus factories around the Golgi complex. Cell Microbiol. 10(10), 2012-2028 (2008).
59. Altamura LA, Bertolotti-Ciarlet A, Teigler J, Paragas J, Schmaljohn CS, Doms RW: Identification of a novel C-terminal cleavage of Crimean-Congo hemorrhagic fever virus PreG that leads to generation of an NS protein. J. Virol. 81(12), 6632-6642 (2007).
60. Pollitt E, Zhao J, Muscat P, Elliott RM: Characterization of Maguari orthobunyavirus mutants suggests the nonstructural protein NS is not essential for growth in tissuem culture. Virology 348(1), 224-232 (2006).
61. Honig JE, Osborne JC, Nichol ST: Crimean-Congo hemorrhagic fever virus genome L RNA segment and encoded protein. Virology 321(1), 29-35 (2004).
62. Kinsella E, Martin SG, Grolla A, Czub M, Feldmann H, Flick R: Sequence determination of the Crimean-Congo hemorrhagic fever virus L segment. Virology 321(1), 23-28 (2004).
63. Isaacson MK, Ploegh HL: Ubiquitination, ubiquitin-like modifiers, and deubiquitination in viral infection. Cell Host Microbe 5(6), 559-570 (2009).
64. Liu YC, Penninger J, Karin M: Immunity by ubiquitylation: a reversible process of modification. Nat. Rev. Immunol. 5(12), 941-952 (2005).
65. Frias-Staheli N, Giannakopoulos NV, Kikkert M et al.: Ovarian tumor domain- containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2(6), 404-416 (2007).
66. Bergeron E, Albarino CG, Khristova ML, Nichol ST: Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor (OTU) protease activity is dispensable for virus RNA polymerase function. J. Virol. 84(1), 216-226 (2009).
67. Lindner HA, Lytvyn V, Qi H, Lachance P, Ziomek E, Menard R: Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease. Arch. Biochem. Biophys. 466(1), 8-14 (2007).
68. Schmaljohn CS, Nichol ST: Bunyaviridae. In: Fields Virology (5th Edition). Knipe DM, Howley PM (Eds). Lippincott Williams and Wilkins, PA, USA (2007).
69. Cash E, Chamorro M, Brahic M: Theiler's virus RNA and protein synthesis in the central nervous system of demyelinating mice. Virology 144(1), 290-294 (1985).
70. Sanchez AJ, Vincent MJ, Nichol ST: Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus. J. Virol. 76(14), 7263-7275 (2002).
71. Sanchez AJ, Vincent MJ, Erickson BR, Nichol ST: Crimean-Congo hemorrhagic fever virus glycoprotein precursor is cleaved by furin-like and SKI-1 proteases to generate a novel 38-kilodalton glycoprotein. J. Virol. 80(1), 514-525 (2006).
72. Vincent MJ, Sanchez AJ, Erickson BR et al.: Crimean-Congo hemorrhagic fever virus glycoprotein proteolytic processing by subtilase SKI-1. J. Virol. 77(16), 8640-8649 (2003).
73. Lenz O, ter Meulen J, Klenk HD, Seidah NG, Garten W: The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc. Natl Acad. Sci. USA 98(22), 12701-12705 (2001).
74. Soellick T, Uhrig JF, Bucher GL, Kellmann JW, Schreier PH: The movement protein NSm of tomato spotted wilt tospovirus (TS WV): RNA binding, interaction with the TSWV N protein, and identification of interacting plant proteins. Proc. Natl Acad. Sci. USA 97(5), 2373-2378 (2000).
75. Shi X, Kohl A, Leonard VH, Li P, McLees A, Elliott RM: Requirement of the N-terminal region of orthobunyavirus nonstructural protein NS for virus assembly and morphogenesis. J. Virol. 80(16), 8089-8099 (2006).
76. Flick R, Flick K, Feldmann H, Elgh F: Reverse genetics for Crimean-Congo hemorrhagic fever virus. J. Virol. 77(10), 5997-6006 (2003).
77. Vassilenko SM, Vassilev TL, Bozadjiev LG, Bineva IL, Kazarov GZ: Specific intravenous immunoglobulin for Crimean-Congo haemorrhagic fever. Lancet 335(8692), 791-792 (1990).
78. Bertolotti-Ciarlet A, Smith J, Strecker K et al.: Cellular localization and antigenic characterization of Crimean-Congo hemorrhagic fever virus glycoproteins. J. Virol. 79(10), 6152-6161 (2005).
79. Andersson I, Simon M, Lundkvist A et al.: Role of actin filaments in targeting of Crimean Congo hemorrhagic fever virus nucleocapsid protein to perinuclear regions of mammalian cells. J. Med. Virol. 72(1), 83-93 (2004).
80. Andersson I, Bladh L, Mousavi-Jazi M et al.: Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus. J. Virol. 78(8), 4323-4329 (2004).
81. Haller O, Kochs G: Interferon-induced Mx proteins: dynamin-like GTPases with antiviral activity. Traffic 3(10), 710-717 (2002).
82. Kochs G, Haener M, Aebi U, Haller O: Self-assembly of human MxA GTPase into highly ordered dynamin-like oligomers. J. Biol. Chem. 277(16), 14172-14176 (2002).
83. Kochs G, Janzen C, Hohenberg H, Haller O: Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes. Proc. Natl Acad. Sci. USA 99(5), 3153-3158 (2002).
84. Frese M, Kochs G, Feldmann H, Hertkorn C, Haller O: Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J. Virol. 70(2), 915-923 (1996).
85. Kanerva M, Melen K, Vaheri A, Julkunen I: Inhibition of puumala and tula hantaviruses in Vero cells by MxA protein. Virology 224(1), 55-62 (1996).
86. Bridgen A, Weber F, Fazakerley JK, Elliott RM: Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis. Proc. Natl Acad. Sci. USA 98(2), 664-669 (2001).
87. Weber F, Bridgen A, Fazakerley JK et al.: Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of a/p interferon. J Virol. 76(16), 7949-7955 (2002).
88. Bouloy M, Janzen C, Vialat P et al.: Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NS$. J. Virol. 75(3), 1371-1377 (2001).
89. Vialat P, Billecocq A, Kohl A, Bouloy M: The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice. J. Virol. 74(3), 1538-1543 (2000).
90. Kohl A, Clayton RF, Weber F, Bridgen A, Randall RE, Elliott RM: Bunyamwera virus nonstructural protein NSs counteracts interferon regulatory factor 3-mediated induction of early cell death. J. Virol. 77(14), 7999-8008 (2003).
91. Bridgen A, Elliott RM: Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs. Proc. Natl Acad. Sci. USA 93(26), 15400-15404 (1996).
92. Habjan M, Penski N, Spiegel M, Weber F: T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus. J. Gen. Virol. 89(Pt 9), 2157-2166 (2008).
93. Blakqori G, Weber F: Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NS$. J. Virol. 79(16), 10420-10428 (2005).
94. Simon M, Johansson C, Mirazimi A: Crimean-Congo hemorrhagic fever virus entry and replication is clathrin-, pH- and cholesterol-dependent. J. Gen. Virol. 90(Pt 1), 210-215 (2009).
95. Marsh M, Helenius A: Virus entry: open sesame. Cell 124(4), 729-740 (2006).
96. Gonzalez-Scarano F, Pobjecky N, Nathanson N: La Crosse bunyavirus can mediate pH-dependent fusion from without. Virology 132(1), 222-225 (1984).
97. Whitfield AE, Ullman DE, German TL: Tomato spotted wilt virus glycoprotein G(C) is cleaved at acidic pH. Virus Res. 110(1-2), 183-186 (2005).
98. Simon M, Johansson C, Lundkvist A, Mirazimi A: Microtubule-dependent and microtubule-independent steps in Crimean- Congo hemorrhagic fever virus replication cycle. Virology 385(2), 313-322 (2009).
99. Chu JJ, Ng ML: Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway. J. Virol. 78(19), 10543-10555 (2004).
100. Suikkanen S, Aaltonen T, Nevalainen M et al.: Exploitation of microtubule cytoskeleton and dynein during parvoviral traffic toward the nucleus. J. Virol. 77(19), 10270-10279 (2003).
101. Boyd A, Fazakerley JK, Bridgen A: Pathogenesis of Dugbe virus infection in wild-type and interferon-deficient mice. J. Gen. Virol. 87(Pt 7), 2005-2009 (2006).
102. Garcin D, Lezzi M, Dobbs M et al.: The 5' ends of Hantaan virus (Bunyaviridae) RNAs suggest a prime-and-realign mechanism for the initiation of RNA synthesis. J. Virol. 69(9), 5754-5762 (1995).
103. Ramanathan HN, Chung DH, Plane SJ et al.: Dynein-dependent transport of the hantaan virus nucleocapsid protein to the endoplasmic reticulum-Golgi intermediate compartment. J. Virol. 81(16), 8634-8647 (2007).
104. Ramanathan HN, Jonsson CB: New and Old World hantaviruses differentially utilize host cytoskeletal components during their life cycles. Virology 374(1), 138-150 (2008).
105. Kuismanen E, Hedman K, Saraste J, Pettersson RF: Uukuniemi virus maturation: accumulation of virus particles and viral antigens in the Golgi complex. Mol. Cell Biol. 2(11), 1444-1458 (1982).
106. Matsuoka Y, Chen SY, Compans RW: Bunyavirus protein transport and assembly. Curr. Top. Microbiol. Immunol. 169, 161-179 (1991).
107. Booth TF, Gould EA, Nuttall PA: Structure and morphogenesis of Dugbe virus (Bunyaviridae, Nairovirus) studied by immunogold electron microscopy of ultrathin cryosections. Virus Res. 21(3), 199-212 (1991).
108. Goldsmith CS, Elliott LH, Peters CJ, Zaki SR: Ultrastructural characteristics of Sin Nombre virus, causative agent of hantavirus pulmonary syndrome. Arch. Virol. 140(12), 2107-2122 (1995).
109. Haferkamp S, Fernando L, Schwarz TF, Feldmann H, Flick R: Intracellular localization of Crimean-Congo hemorrhagic fever (CCHF) virus glycoproteins. Virol. J. 2, 42 (2005).
110. Luini A, Mironov AA, Polishchuk EV, Polishchuk RS: Morphogenesis of post-Golgi transport carriers. Histochem. Cell Biol. 129(2), 153-161 (2008).
111. WHO: Geographic distribution of Crimean-Congo hemorrhagic fever "http://www.who.int/csr/disease/crimean-congoHF/www.who.int/csr/disease/ crimeancongoHF/Global-CCHFRisk-20080918.png